Skip to main content
OpenTrials

Clinical trial condition

Hereditary Complement Deficiency Diseases

Explore clinical trials studying Hereditary Complement Deficiency Diseases. Study availability and eligibility vary by location and protocol.

145 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Complement Deficiency Diseases trial results

Completed

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

NCT01386658

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Breathe America Shreveport, Louisiana, United States
  • Institute for Asthma and Allergy, PC Chevy Chase, Maryland, United States
View all 26 locations
View Trial Details
Completed

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

NCT01059526

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Little Rock Allergry and Asthma Clinical Research Center Little Rock, Arkansas, United States
  • Sunrise Clinical Research Bell Gardens, California, United States
  • Allergy & Asthma Institute of the Valley Granada Hills, California, United States
  • Unidversity of California, Los Angeles David Geffen School of Medicine Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00438815

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 30 locations
View Trial Details
Completed

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

NCT02741596

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 43 locations
View Trial Details
Completed

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

NCT00457015

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Aaron J. Davis Scottsdale, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
View all 45 locations
View Trial Details
Completed

Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

NCT02052141

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Asthma and Allergy Associates, P.C Colorado Springs, Colorado, United States
  • Nevada Access to Research and Education Society Las Vegas, Nevada, United States
  • Oregon Allergy Associates Eugene, Oregon, United States
  • Klinikum der J.W. Goethe Universitat Frankfurt, Germany
View Trial Details
Completed

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

NCT01095510

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Asthma & Allergy Associates, P.C. Colorado Springs, Colorado, United States
  • University of South Florida Asthma, Allergy and Immunology Clinical Research Unit Tampa, Florida, United States
  • Institute for Asthma and Allergy, PC Chevy Chase, Maryland, United States
  • Allergy & Asthma Research Group Eugene, Oregon, United States
View Trial Details
Completed

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

NCT01756157

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • ViroPharma Investigational Site Birmingham, Alabama, United States
  • ViroPharma Investigational Site Scottsdale, Arizona, United States
  • ViroPharma Investigational Site Bentonville, Arkansas, United States
  • ViroPharma Investigational Site Walnut Creek, California, United States
View all 23 locations
View Trial Details

Related conditions